DNA testing | GenomeWeb

DNA testing

Decisions, Decisions

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

The DNA testing services provider said the acquisition will help it to grow its business in southern Florida, where All About Truth is based. 

MSK will collect the samples and Illumina will analyze them for ctDNA using its sequencing technology.

The initiative aims to integrate clinical, genomic, environmental, and other data from patients to help determine disease mechanisms and develop precise therapies.

Life Technologies said this week that it has become the exclusive worldwide distributor for LGC Forensics' recently launched ParaDNA platform, a portable DNA testing system designed to determine the quality of human DNA more quickly and efficiently than existing methods.

The companies have developed a beta version of their platform, RapI.D., and have begun internal tests with the hope of field testing it by the beginning of next year.

ZyGem's acquisition of MicroLab Diagnostics, announced this week, is expected to accelerate the company's transformation from a provider of DNA extraction products to a purveyor of fully integrated DNA-testing platforms for the forensics, biodefense, and eventually clinical diagnostics markets.

An ASHG task force has issued a white paper urging stakeholder cooperation in addressing the vague and confusing nature of ancestral genetic information presented in consumer services.

Orchid has acquired the paternity and immigration DNA testing business unit from Strand Analytical Laboratories.

Pages

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.